163 related articles for article (PubMed ID: 34678611)
1. Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation.
Bonnet B; Cosme J; Dupuis C; Coupez E; Adda M; Calvet L; Fabre L; Saint-Sardos P; Bereiziat M; Vidal M; Laurichesse H; Souweine B; Evrard B
EBioMedicine; 2021 Nov; 73():103622. PubMed ID: 34678611
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of the immune response in coronavirus disease 2019.
Mohamed Khosroshahi L; Rezaei N
Cell Biol Int; 2021 Apr; 45(4):702-707. PubMed ID: 33289192
[TBL] [Abstract][Full Text] [Related]
3. Case Report: Interferon-γ Restores Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) in Severe COVID-19 With Acquired Immunosuppression Syndrome.
Dickel S; Grimm C; Amschler K; Schnitzler SU; Schanz J; Moerer O; Payen D; Tampe B; Winkler MS
Front Immunol; 2021; 12():645124. PubMed ID: 33897692
[TBL] [Abstract][Full Text] [Related]
4. Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection.
Roussel M; Ferrant J; Reizine F; Le Gallou S; Dulong J; Carl S; Lesouhaitier M; Gregoire M; Bescher N; Verdy C; Latour M; Bézier I; Cornic M; Vinit A; Monvoisin C; Sawitzki B; Leonard S; Paul S; Feuillard J; Jeannet R; Daix T; Tiwari VK; Tadié JM; Cogné M; Tarte K
Cell Rep Med; 2021 Jun; 2(6):100291. PubMed ID: 33977279
[TBL] [Abstract][Full Text] [Related]
5. Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock.
Venet F; Tissot S; Debard AL; Faudot C; Crampé C; Pachot A; Ayala A; Monneret G
Crit Care Med; 2007 Aug; 35(8):1910-7. PubMed ID: 17568330
[TBL] [Abstract][Full Text] [Related]
6. Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections.
Lekkou A; Karakantza M; Mouzaki A; Kalfarentzos F; Gogos CA
Clin Diagn Lab Immunol; 2004 Jan; 11(1):161-7. PubMed ID: 14715564
[TBL] [Abstract][Full Text] [Related]
7. Monocyte HLA-DR Measurement by Flow Cytometry in COVID-19 Patients: An Interim Review.
Benlyamani I; Venet F; Coudereau R; Gossez M; Monneret G
Cytometry A; 2020 Dec; 97(12):1217-1221. PubMed ID: 33125816
[TBL] [Abstract][Full Text] [Related]
8. Triggering receptor expressed on myeloid cells-1 expression on monocytes is associated with inflammation but not with infection in acute pancreatitis.
Ferat-Osorio E; Wong-Baeza I; Esquivel-Callejas N; Figueroa-Figueroa S; Duarte-Rojo A; Guzmán-Valdivia-Gómez G; Rodea-Rosas H; Torres-González R; Sánchez-Fernández P; Arriaga-Pizano L; López-Macías C; Robles-Díaz G; Isibasi A
Crit Care; 2009; 13(3):R69. PubMed ID: 19442309
[TBL] [Abstract][Full Text] [Related]
9. Monocytes and Macrophages in COVID-19.
Knoll R; Schultze JL; Schulte-Schrepping J
Front Immunol; 2021; 12():720109. PubMed ID: 34367190
[TBL] [Abstract][Full Text] [Related]
10. An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis.
Liu Y; Chen D; Hou J; Li H; Cao D; Guo M; Ling Y; Gao M; Zhou Y; Wan Y; Zhu Z
Cytokine; 2021 Feb; 138():155365. PubMed ID: 33246770
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis.
Berres ML; Schnyder B; Yagmur E; Inglis B; Stanzel S; Tischendorf JJ; Koch A; Winograd R; Trautwein C; Wasmuth HE
Liver Int; 2009 Apr; 29(4):536-43. PubMed ID: 18795898
[TBL] [Abstract][Full Text] [Related]
12. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections.
Remy KE; Mazer M; Striker DA; Ellebedy AH; Walton AH; Unsinger J; Blood TM; Mudd PA; Yi DJ; Mannion DA; Osborne DF; Martin RS; Anand NJ; Bosanquet JP; Blood J; Drewry AM; Caldwell CC; Turnbull IR; Brakenridge SC; Moldwawer LL; Hotchkiss RS
JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32687484
[TBL] [Abstract][Full Text] [Related]
13. The Comparison of Monocyte Human Leukocyte Antigen-D-Related (mHLA-DR) Expression Levels Between Corona Virus Disease 2019 (COVID-19) Patients and Healthy Subjects.
Nabilah MH; Wardhani P; Aryati A; Hernaningsih Y; Semedi BP
Acta Med Indones; 2023 Jan; 55(1):52-60. PubMed ID: 36999265
[TBL] [Abstract][Full Text] [Related]
14. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.
Wang J; Yang X; Li Y; Huang JA; Jiang J; Su N
Virol J; 2021 Jun; 18(1):117. PubMed ID: 34088317
[TBL] [Abstract][Full Text] [Related]
15. Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19.
Vassiliou AG; Dimopoulou I; Jahaj E; Keskinidou C; Mastora Z; Orfanos SE; Kotanidou A
In Vivo; 2021; 35(2):1295-1298. PubMed ID: 33622933
[TBL] [Abstract][Full Text] [Related]
16. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
Wilson JG; Simpson LJ; Ferreira AM; Rustagi A; Roque J; Asuni A; Ranganath T; Grant PM; Subramanian A; Rosenberg-Hasson Y; Maecker HT; Holmes SP; Levitt JE; Blish CA; Rogers AJ
JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32706339
[TBL] [Abstract][Full Text] [Related]
17. Classical monocytes-low expressing HLA-DR is associated with higher mortality rate in SARS-CoV-2+ young patients with severe pneumonia.
Henao-Agudelo JS; Ayala S; Badiel M; Zea-Vera AF; Matta Cortes L
Heliyon; 2024 Jan; 10(2):e24099. PubMed ID: 38268832
[TBL] [Abstract][Full Text] [Related]
18. Along with PaO2/FiO2 ratio and lymphopenia, low HLA-DR monocytes are the only additional parameter that independently predicts the clinical course of undifferentiated SARS-CoV-2 patients in emergency departments.
Lafon T; Chapuis N; Guerin E; Daix T; Otranto M; Boumediene A; Jeannet R; Fontenay M; Henri Hani K; Vignon P; Monneret G; François B; Jean-Philippe J; Feuillard J
J Leukoc Biol; 2024 May; 115(6):1131-1142. PubMed ID: 38366559
[TBL] [Abstract][Full Text] [Related]
19. Systemic inflammation as fuel for acute liver injury in COVID-19.
Effenberger M; Grander C; Grabherr F; Griesmacher A; Ploner T; Hartig F; Bellmann-Weiler R; Joannidis M; Zoller H; Weiss G; Adolph TE; Tilg H
Dig Liver Dis; 2021 Feb; 53(2):158-165. PubMed ID: 32873520
[TBL] [Abstract][Full Text] [Related]
20. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
